

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact...


IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team


* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses pr...


IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened


UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next


By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University ...


UK DIRECTOR DEALINGS SUMMARY: Oxford BioMedica Non-Exec And Wife Sell


Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development